BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17024368)

  • 1. High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array.
    Hayashi H; Nagae G; Tsutsumi S; Kaneshiro K; Kozaki T; Kaneda A; Sugisaki H; Aburatani H
    Hum Genet; 2007 Jan; 120(5):701-11. PubMed ID: 17024368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.
    Fahrner JA; Eguchi S; Herman JG; Baylin SB
    Cancer Res; 2002 Dec; 62(24):7213-8. PubMed ID: 12499261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.
    Rauch T; Wang Z; Zhang X; Zhong X; Wu X; Lau SK; Kernstine KH; Riggs AD; Pfeifer GP
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5527-32. PubMed ID: 17369352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
    Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
    Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.
    Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K
    Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing.
    Wu J; Wang SH; Potter D; Liu JC; Smith LT; Wu YZ; Huang TH; Plass C
    BMC Genomics; 2007 May; 8():131. PubMed ID: 17524140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
    Wiencke JK; Zheng S; Morrison Z; Yeh RF
    Oncogene; 2008 Apr; 27(17):2412-21. PubMed ID: 17968314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
    Yamashita S; Takahashi S; McDonell N; Watanabe N; Niwa T; Hosoya K; Tsujino Y; Shirai T; Ushijima T
    Cancer Res; 2008 Apr; 68(7):2112-21. PubMed ID: 18381416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated map of p53-binding sites and histone modification in the human ENCODE regions.
    Kaneshiro K; Tsutsumi S; Tsuji S; Shirahige K; Aburatani H
    Genomics; 2007 Feb; 89(2):178-88. PubMed ID: 17085012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells.
    Meng CF; Su B; Li W
    Mol Med Rep; 2011; 4(6):1273-8. PubMed ID: 21850374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
    Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
    PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.
    Liu Y; Hong Y; Zhao Y; Ismail TM; Wong Y; Eu KW
    Cancer Invest; 2008 Jul; 26(6):575-82. PubMed ID: 18584348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.